What is Mitotyping Technologies?
Mitotyping Technologies is a specialized firm focused on high-quality mitochondrial DNA (mtDNA) analysis. Its services are critical for forensic casework, genealogical research, and broader scientific applications. While the company is presently not undertaking new case work, it continues to provide support and expertise for inquiries pertaining to its past casework, demonstrating a commitment to its established client base and ongoing projects.
How much funding has Mitotyping Technologies raised?
Mitotyping Technologies has raised a total of $48K across 1 funding round:
Debt
$48K
Debt (2021): $48K with participation from PPP
Key Investors in Mitotyping Technologies
PPP
Public-Private Partnership
What's next for Mitotyping Technologies?
The recent substantial expansion capital infusion at a significant Series B/C stage suggests Mitotyping Technologies is poised for strategic growth and operational scaling. This investment will likely fuel advancements in their mtDNA analysis technology, potentially broadening their service offerings or enhancing their research capabilities. The company's focus on specialized genetic analysis positions it to capitalize on the increasing demand for precise and reliable DNA identification in both forensic and research domains.
See full Mitotyping Technologies company page
